scholarly journals Risk Factors of Metabolic Syndrome among Polish Nurses

Metabolites ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 267
Author(s):  
Anna Bartosiewicz ◽  
Edyta Łuszczki ◽  
Małgorzata Nagórska ◽  
Łukasz Oleksy ◽  
Artur Stolarczyk ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Weight Control ◽  
Professional Group ◽  
Overweight And Obesity ◽  
World Health ◽  
Dietary Recommendations ◽  
Obesity Class ◽  
The Metabolic Syndrome ◽  
The World

The metabolic syndrome, also known as syndrome X or the insulin resistance, is defined by the World Health Organization as a pathologic condition characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia. Both all over the world and in Poland, there is a shortage of nurses; most of those employed are in the pre-retirement age. However, the requirements in this profession and the patient’s right to care at the highest level remain unchanged and do not take into account the poor condition or age of working nurses, so special attention should be paid to the state of health in this professional group. There is an emphasis on the importance of the adopted attitude toward health and the resulting behaviors, such as regular weight control, following dietary recommendations, regular physical activity and participation in preventive examinations. The aim of the study was to assess the frequency of the occurrence of the metabolic syndrome, its individual components and determining the factors influencing its development in Polish nurses. The research conducted among the nurses in question included DXA (Dual Energy X-ray Absorptiometry) measurements, assessment of glucose concentration, lipid profile, blood pressure and a questionnaire survey. Almost half of the surveyed nurses have metabolic syndrome, which significantly increases the risk of developing cardiovascular diseases or diabetes. After multivariate analysis, it was found that being overweight and obesity were significant factors influenced the MS (metabolic syndrome) occurrence among Polish nurses. Being overweight increases the chances of MS occurrence 8.58 times in relation to BMI (Body Mass Index) <25, obesity increases the chances of MS occurrence 8.085 times in relation to BMI <25, and obesity class II/III increases the chances of MS occurrence 16.505 times in relation to BMI <25. Preventive and supportive measures for this professional group are needed.

scholarly journals Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study

2020 ◽  
Vol 36 (8) ◽  
Author(s):  
Maria de Fátima Haueisen Sander Diniz ◽  
Alline Maria Rezende Beleigoli ◽  
Maria Inês Schmidt ◽  
Bruce B. Duncan ◽  
Antônio Luiz P. Ribeiro ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Normal Weight ◽  
Overweight And Obesity ◽  
Model Assessment ◽  
Adult Health ◽  
Homeostasis Model Assessment ◽  
The Metabolic Syndrome ◽  
Brazilian Cohort ◽  
Overweight Or Obesity

Abstract: Homeostasis model assessment of insulin resistance (HOMA-IR) is a method to measure insulin resistance. HOMA-IR cut-offs for identifying metabolic syndrome might vary across populations and body mass index (BMI) levels. We aimed to investigate HOMA-insulin resistance cut-offs that best discriminate individuals with insulin resistance and with metabolic syndrome for each BMI category in a large sample of adults without diabetes in the baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Among the 12,313 participants with mean age of 51.2 (SD 8.9) years, the prevalence of metabolic syndrome was 34.6%, and 60.1% had overweight or obesity. The prevalence of metabolic syndrome among normal weight, overweight and obesity categories were, respectively, 13%, 43.2% and 60.7%. The point of maximum combined sensitivity and specificity of HOMA-IR to discriminate the metabolic syndrome was 2.35 in the whole sample, with increasing values at higher BMI categories. This investigation contributes to better understanding HOMA-IR values associated with insulin resistance and metabolic syndrome in a large Brazilian adult sample, and that use of cut-off points according to ROC curve may be the better strategy. It also suggests that different values might be appropriate across BMI categories.

scholarly journals Salud electrónica para el autocuidado de pacientes con factores de riesgo asociados al síndrome metabólico

2016 ◽  
Vol 18 (1) ◽  
pp. 170 ◽  
Author(s):  
Consuelo Vélez Álvarez ◽  
José Armando Vidarte Claros ◽  
Rosa Elvira Álvarez Rosero ◽  
Jully Andrea García Navarro
Keyword(s):  
Risk Factors ◽  
Metabolic Syndrome ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Overweight And Obesity ◽  
World Health ◽  
Factors Associated ◽  
The Metabolic Syndrome ◽  
Síndrome Metabólico ◽  
Factores De Riesgo

ResumenEl propósito de esta revisión, es identificar la evidencia científica sobre el uso de estrategias de salud electrónica en las intervenciones dirigidas a mejorar el autocuidado de pacientes con factores de riesgo cardiovascular asociado con la presencia de síndrome metabólico. Los artículos analizados fueron identificados en las bases de datos PubMed, Science Direct, Embase, Elsevier, Scielo, Adicional a esto se revisaron publicaciones estadísticas de la Organización Mundial de la Salud, La Federación Internacional de Diabetes, Guía de Síndrome Metabólico 2009 y ICT Facts and Figures World in 2013. Se tuvieron en cuenta 51 publicaciones realizadas entre los años 2009 y 2015, encontrándose mayor información en la intervención basada en el control del sobrepeso y la obesidad, como principal factor de riesgo para el desarrollo del síndrome metabólico. La evidencia encontrada en la literatura científica muestra la utilidad de la salud electrónica en el manejo de los factores de riesgo cardiovasculares asociados al síndrome metabólico, y el impacto de esta en la calidad de vida cuando son aplicadas con un adecuado protocolo.  AbstractThe purpose of this review is to identify the scientific evidence on the use of electronic health strategies in interventions aimed at improving self-care of patients with cardiovascular risk factors associated with the presence of metabolic syndrome. The articles analyzed were identified in the databases PubMed, Science Direct, Embase, Elsevier and Scielo. In addition, statistical publications from the World Health Organization, the International Diabetes Federation, Metabolic Syndrome Guide 2009 and ICT Facts and Figures World in 2013 were reviewed. 51 publications between the years 2009 and 2015 were considered, where there were more information about the intervention based on the control of overweight and obesity as a major risk factor for the development of the metabolic syndrome. The evidence found in the scientific literature shows the usefulness of e-health in the management of cardiovascular risk factors associated with metabolic syndrome, and its impact on the quality of life when they are applied with a suitable protocol.

Efficacy of Herbal Medicine in Treating Metabolic and Endocrine Disorders

2021 ◽  
pp. 236-255
Author(s):  
Chittipolu Ajaykumar
Keyword(s):  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Herbal Medicine ◽  
Modern Medicine ◽  
Dosage Forms ◽  
Syndrome X ◽  
Endocrine Disorders ◽  
Evidence Based ◽  
The Metabolic Syndrome ◽  
The World

Metabolic syndrome is an interrelated cluster of pathogens such as obesity, impaired glucose tolerance, cancer, and insulin resistance leading to endocrinal disorders. In the 21st century, progression of the disease is rapid increases due to change in the lifestyle of humans having a chance to develop metabolic change, and in some cases, mutations occur, which drastically affects the endocrine functionality and subsequently causes syndrome X. In modern medicine, different medications are available but only to maintain the condition lifetime. For the complete cure, WHO focused on the traditional knowledge in 2004, using the herbal medicine to cure all metabolic aliments. According to ancient medical treatment, metabolic syndromes are completely curable. They divided the disease progression stages and formulated the different dosage forms. All the data obtained from the ancient herbal medicine treatment are not evidence-based. So, the researchers all around the world focused on the evidence-based proofs to confirm whether herbal medicine shows efficacy in curing the metabolic syndrome or not.

scholarly journals Overview of the epidemic overweight and obesity in Mexico

2020 ◽  
Vol 8 (16) ◽  
pp. 65-71
Author(s):  
Miriam Selene Hernández Medina
Keyword(s):  
Public Policies ◽  
Overweight And Obesity ◽  
World Health ◽  
Noncommunicable Diseases ◽  
Excess Body Weight ◽  
The Metabolic Syndrome ◽  
Starting Point ◽  
The World ◽  
Control And Prevention ◽  
Health Organization

Changes in nutrition and population are intimately related in several ways. According to the World Health Organization (WHO), since 1997, overweight and obesity have been recognized as public health problems, both in developed and developing countries, reaching epidemic proportions worldwide, each year around 2.8 million people die because of them. Overweight and obesity are the starting point for pathologies such as the metabolic syndrome, arterial hypertension, dyslipidemia and coronary heart disease. Mexico has been immersed in this epidemic, with the information provided by the National Nutrition and Health Surveys since 1988 it has been possible to document the permanent tendency to increase Overweight and Obesity. It has been widely documented that the increase in obesity throughout the world is closely linked to food policies, understood as one of the structural social determinants of health. Healthy public policies should be formulated to promote the prevention and control of Chronic Noncommunicable Diseases and reorient health systems so that they meet the needs of people suffering from excess body weight. The objective of this article is to know the factors that have driven the generation of programs, strategies and public policies around the epidemic of Overweigth and Obesity in order to ensure its control and prevention in the Mexican population.

Prevalence of metabolic syndrome in never treated mood disordered patientss

2007 ◽  
Vol 30 (4) ◽  
pp. 95
Author(s):  
Valerie Taylor ◽  
Glenda M. MacQueen
Keyword(s):  
Metabolic Syndrome ◽  
Mood Disorders ◽  
Population Attributable Risk ◽  
Disease Process ◽  
Visceral Obesity ◽  
Premature Mortality ◽  
Overweight And Obesity ◽  
The Metabolic Syndrome ◽  
Increased Risk ◽  
Bipolar Patients

Bipolar disorder and major depression are life-shortening illnesses. Unnatural causes such as suicide and accidents account for only a portion of this premature mortality1 Research is beginning to identify that mood disordered patients have a higher incidence of metabolic syndrome, an illness characterized by dyslipidemia, impaired glucose tolerance, hypertension and obesity.2 Metabolic syndrome is associated with an increased risk for a variety of physical illnesses. Hypothesis: Never treated patients with mood disorders have preexisting elevations in the prevalence of the component variables of metabolic syndrome. Central obesity will be especially elevated, predicting increased premature mortality. Methods: We assessed never treated patients with mood disorders for metabolic syndrome and its component variables. Patients were assessed at baseline and followed up at 6-month intervals. All psychiatric pharmacotherapy was documented. Body mass index (BMI) was also obtained and the percentage of deaths attributable to overweight and obesity was calculated using the population attributable risk (PAR). [PAR= ∑[P (RR-1)/RR] Results: Prior to the initiation of treatment, patients did not differ from population norms with respect to metabolic syndrome or BMI. At 2-year follow-up, BMI had increased for unipolar patients 2.02 points and 1.92 points for bipolar patients. (p < .001) This increase in BMI predicted an increase in mortality of 19.4%. Conclusion: An increase in visceral obesity is often the first component of metabolic syndrome to appear and may indicate the initiation of this disease process prematurely in this group. The increase in BMI places patients with mood disorders at risk for premature mortality and indicates a need for early intervention. References 1.Osby U, Brandt L, Correia N, Ekbom A & Sparen P. Excess mortability in bipolar and Unipolar disorder rin Sweden. Archives of General Psychiatry, 2001;58: 844-850 2.Toalson P, Saeeduddin A, Hardy T & Kabinoff G. The metabolic syndrome in patients with severe mental illness. Journal of Clinical Psychiatry, 2004; 6(4): 152-158

Metabolic Syndrome During Menopause

2019 ◽  
Vol 17 (6) ◽  
pp. 595-603 ◽  
Author(s):  
Sezcan Mumusoglu ◽  
Bulent Okan Yildiz
Keyword(s):  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Central Obesity ◽  
Polycystic Ovary ◽  
Ovary Syndrome ◽  
Natural Menopause ◽  
The Metabolic Syndrome ◽  
Increased Risk ◽  
Aging Women

The metabolic syndrome (MetS) comprises individual components including central obesity, insulin resistance, dyslipidaemia and hypertension and it is associated with an increased risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). The menopause per se increases the incidence of MetS in aging women. The effect(s) of menopause on individual components of MetS include: i) increasing central obesity with changes in the fat tissue distribution, ii) potential increase in insulin resistance, iii) changes in serum lipid concentrations, which seem to be associated with increasing weight rather than menopause itself, and, iv) an association between menopause and hypertension, although available data are inconclusive. With regard to the consequences of MetS during menopause, there is no consistent data supporting a causal relationship between menopause and CVD. However, concomitant MetS during menopause appears to increase the risk of CVD. Furthermore, despite the data supporting the association between early menopause and increased risk of T2DM, the association between natural menopause itself and risk of T2DM is not evident. However, the presence and the severity of MetS appears to be associated with an increased risk of T2DM. Although the mechanism is not clear, surgical menopause is strongly linked with a higher incidence of MetS. Interestingly, women with polycystic ovary syndrome (PCOS) have an increased risk of MetS during their reproductive years; however, with menopausal transition, the risk of MetS becomes similar to that of non-PCOS women.

Sign in / Sign up

Export Citation Format

Share Document